Questcor®

For assistance with any problem or issue, please contact customer service at 1.800.411.3065 (M-F from 8:00 a.m. to 4:00 p.m. Pacific Standard Time.)

In the event of an emergency, please contact us 24 hours a day, 7 days a week at 1.800.411.3065

Working for a small company like Questcor allows you the opportunity to express and implement your own unique ideas. The company encourages professional growth without boundaries.

-Christine T.
Acthar Specialist

Questcor's working environment has allowed me to be successful by offering an excellent management team, realistic attainable goals, and a competitive compensation plan.

-Doug D.
Regional Manager

Hard work, teamwork, and a can-do spirit personify the people and the culture at Questcor.

-Todd B.
Regional Manager

Working at Questcor has been a rewarding growth opportunity both personally and professionally. Over the years and through many changes in the company, it has been a great experience to work with so many talented people who are focused on improving the lives of patients suffering from CNS and inflammatory disorders.

-Heather B.
Market Research

This is a place where your ideas and opinions not only matter, but are encouraged. Truly unique, like no other company you will work for, a company with a very bright future.

-Matthew D.
Regional Manager

For me working at Questcor has been great. The company culture is excellent; I have a diversity of responsibilities, and most importantly I have very good work/life balance.

-Temi O.
Finance and Accounting

H.P. Acthar^® Gel (repository corticotropin injection) is indicated for the treatment of acute exacerbations in patients with multiple sclerosis, for the diagnosis of adrenocortical function, and for several other uses.

Acthar Delivers Proven Relief of MS Exacerbations

No differences in efficacy shown between Acthar and IV steroids

Acthar effectively accelerates recovery from acute MS exacerbations and improves patients' disability scores[1][2][3][4]

In multiple head-to-head clinical studies, there were no demonstrated differences between the efficacy of IV steroids and ACTH[1][3][5]

Some Patients Need an Alternative to IV Steroids

Consider Acthar when your patients...

Have poor venous access
Express tolerability concerns with IV steroids
Report an inadequate response to IV steroids
Need the flexibility of a self-injection at home or work

Find out more information about our ASAP Program.

Find out more information about H.P. Acthar Gel on our Acthar product website.

References

^ Thompson AJ, Kennard C, Swash M, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 1989;39:969-971.
^ H.P. Acthar^® Gel (repository corticotropin injection), prescribing information, Questcor Pharmaceuticals, Inc.
^ Milanese C, La Mantia L, Salmaggi A, et al. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Eur Neurol. 1989;29:10-14.
^ Rose AS, Kuzma JW, Kurtzke JF, et al. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo-final report. Neurology. 1970:20:1-59.
^ Barnes MP, Bateman DE, Cleland PG, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry. 1985;48:157-159.